Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,617 | -38,115 | -176,353 | -114,363 | -61,343 |
| Depreciation Amortization | 29,421 | 13,904 | 41,913 | 41,677 | 27,045 |
| Income taxes - deferred | -4,722 | -179 | -8,905 | -19,212 | -9,722 |
| Accounts receivable | -4,384 | 7,406 | -8,740 | -15,679 | -5,997 |
| Other Working Capital | -43,550 | -26,744 | -8,100 | -21,021 | -32,020 |
| Other Operating Activity | 56,894 | 17,235 | 102,850 | 80,260 | 43,191 |
| Operating Cash Flow | $-37,958 | $-26,493 | $-57,335 | $-48,338 | $-38,846 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -13,254 | -14,915 | -106,399 | 53,433 | 36,918 |
| PPE Investments | -64,125 | -23,607 | -181,693 | -35,440 | -22,238 |
| Net Acquisitions | N/A | N/A | -9,875 | -9,875 | -9,875 |
| Purchase Of Investment | N/A | N/A | N/A | -485 | -485 |
| Other Investing Activity | -1,500 | 0 | -885 | 0 | 0 |
| Investing Cash Flow | $-78,879 | $-38,522 | $-298,852 | $7,633 | $4,320 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 726,202 | N/A | N/A |
| Common Stock Issued | 145,566 | 137,176 | 72,579 | 60,229 | 45,782 |
| Common Stock Repurchased | N/A | N/A | -29,813 | N/A | N/A |
| Other Financing Activity | -11,761 | -212 | -22,297 | -18,486 | -16,338 |
| Financing Cash Flow | $133,805 | $136,964 | $746,671 | $41,743 | $29,444 |
| Exchange Rate Effect | -1,032 | -952 | -2,230 | N/A | N/A |
| Beginning Cash Position | 568,781 | 568,781 | 180,527 | 180,527 | 180,527 |
| End Cash Position | 584,717 | 639,778 | 568,781 | 181,565 | 175,445 |
| Net Cash Flow | $15,936 | $70,997 | $388,254 | $1,038 | $-5,082 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,958 | -26,493 | -57,335 | -48,338 | -38,846 |
| Capital Expenditure | -64,125 | -23,607 | -181,693 | -35,440 | -22,238 |
| Free Cash Flow | -102,083 | -50,100 | -239,028 | -83,778 | -61,084 |